{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T10:25:08Z","timestamp":1768559108183,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12933-015-0270-8","type":"journal-article","created":{"date-parts":[[2015,8,13]],"date-time":"2015-08-13T00:45:51Z","timestamp":1439426751000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Alterations in lipid transfers to HDL associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus"],"prefix":"10.1186","volume":"14","author":[{"given":"Marilia C O","family":"Sprandel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Whady A","family":"Hueb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Segre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 A F","family":"Ramires","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Kalil-Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raul C","family":"Maranh\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,8,14]]},"reference":[{"key":"270_CR1","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/heartjnl-2011-301172","volume":"99","author":"G Pasterkamp","year":"2013","unstructured":"Pasterkamp G (2013) Methods of accelerated atherosclerosis in diabetic patients. Heart 99:743\u2013749","journal-title":"Heart"},{"key":"270_CR2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/1475-2840-12-173","volume":"12","author":"CC Lean\u00e7a","year":"2013","unstructured":"Lean\u00e7a CC, Nunes VS, Panzoldo NB, Zago VS, Parra ES, Cazita PM et al (2013) Metabolism of plasma cholesterol and lipoprotein parameters are related to a higher degree of insulin sensitivity in high HDL-C healthy normal weight subjects. Cardiovasc Diabetol 12:173","journal-title":"Cardiovasc Diabetol"},{"key":"270_CR3","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/ncpendmet1066","volume":"5","author":"AD Mooradian","year":"2009","unstructured":"Mooradian AD (2009) Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab 5:150\u2013159","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"270_CR4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1475-2840-13-26","volume":"13","author":"JC Fruchart","year":"2014","unstructured":"Fruchart JC, Davignon J, Hermans MP, Al-Rubeaan K, Amarenco P,\u00a0Assmann G et al (2014) Residual macrovascular risk in 2013: what have we learned? Cardiovasc Diabetol 13:26","journal-title":"Cardiovasc Diabetol"},{"key":"270_CR5","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.metabol.2014.03.001","volume":"63","author":"HN Yassine","year":"2014","unstructured":"Yassine HN, Belopolskaya A, Schall C, Stump CS, Lau SS, Reaven PD (2014) Enhanced cholesterol efflux to HDL through the ABCA1 transporter in hypertriglyceridemia of type 2 diabetes. Metabolism 63:727\u2013734","journal-title":"Metabolism"},{"key":"270_CR6","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0002-9343(77)90874-9","volume":"62","author":"T Gordon","year":"1977","unstructured":"Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR (1977) High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 62:707\u2013714","journal-title":"Am J Med"},{"key":"270_CR7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.79.1.8","volume":"79","author":"DJ Gordon","year":"1989","unstructured":"Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP,\u00a0Knoke JD et al (1989) High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 79:8\u201315","journal-title":"Circulation"},{"key":"270_CR8","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.jacc.2013.07.051","volume":"62","author":"S Acharjee","year":"2013","unstructured":"Acharjee S, Boden WE, Hartigan PM, Teo KK, Maron DJ,\u00a0Sedlis SP et al (2013) Low Levels of high density lipoprotein cholesterol and increased risk of cardiovascular events in stable ischemic heart disease patients: a post hoc analysis from the COURAGE Trial. J Am Coll Cardiol 62:1826\u20131833","journal-title":"J Am Coll Cardiol"},{"key":"270_CR9","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/pr.58.3.1","volume":"58","author":"A Kontush","year":"2006","unstructured":"Kontush A, Chapman MJ (2006) Functionally defective high-density lipoprotein: a newtherapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol Rev 58:342\u2013374","journal-title":"Pharmacol Rev"},{"key":"270_CR10","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1161\/CIRCULATIONAHA.111.066589","volume":"125","author":"RS Rosenson","year":"2012","unstructured":"Rosenson RS, Brewer HB Jr, Davidson WS, Fayad ZA, Fuster V,\u00a0Goldstein J et al (2012) Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport. Circulation 125:1905\u20131919","journal-title":"Circulation"},{"key":"270_CR11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev.bi.64.070195.001315","volume":"64","author":"A Tall","year":"1995","unstructured":"Tall A (1995) Plasma lipid transfer proteins. Ann Rev Biochem 64:235\u2013257","journal-title":"Ann Rev Biochem"},{"key":"270_CR12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/CIRCRESAHA.113.300689","volume":"113","author":"AL Siebel","year":"2013","unstructured":"Siebel AL, Natoli AK, Yap FY, Carey AL, Reddy-Luthmoodoo M,\u00a0Sviridov D et al (2013) Effects of high-density lipoprotein elevation with cholesteryl ester transfer protein inhibition on insulin secretion. Circ Res 113:167\u2013175","journal-title":"Circ Res"},{"key":"270_CR13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cca.2014.09.035","volume":"439","author":"A Abbasi","year":"2015","unstructured":"Abbasi A, Dallinga-Thie GM, Dullaart RP (2015) Phospholipid transfer protein activity and incident type 2 diabetes mellitus. Clin Chim Acta 439:38\u201341","journal-title":"Clin Chim Acta"},{"key":"270_CR14","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1194\/jlr.R024075","volume":"53","author":"PJ Barter","year":"2012","unstructured":"Barter PJ, Rye KA (2012) Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk. J Lipid Res 53:1755\u20131766","journal-title":"J Lipid Res"},{"key":"270_CR15","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1007\/s00125-012-2570-9","volume":"55","author":"H Low","year":"2012","unstructured":"Low H, Hoang A, Forbes J, Thomas M, Lyons JG,\u00a0Nestel P et al (2012) Advanced glycation end-products (AGEs) and functionality of reverse cholesterol transport in patients with type 2 diabetes and in mouse models. Diabetologia 55:2513\u20132521","journal-title":"Diabetologia"},{"key":"270_CR16","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s11745-009-3342-2","volume":"44","author":"AC Lo Prete","year":"2009","unstructured":"Lo Prete AC, Dina CH, Azevedo CH, Puk CG, Lopes NH,\u00a0Hueb WA et al (2009) In vitro simultaneous transfer of lipids to HDL in coronary artery disease and in statin treatment. Lipids 44:917\u2013924","journal-title":"Lipids"},{"key":"270_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-800141-7.00001-2","volume":"65","author":"RC Maranhao","year":"2014","unstructured":"Maranhao RC, Freitas FR (2014) HDL metabolism and atheroprotection: predictive value of lipid transfers. Adv Clin Chem 65:1\u201341","journal-title":"Adv Clin Chem"},{"key":"270_CR18","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.cca.2011.11.011","volume":"413","author":"RC Maranhao","year":"2012","unstructured":"Maranhao RC, Freitas FR, Strunz CM, Santos RD, Mansur AJ,\u00a0Mansur AP et al (2012) Lipid transfers to HDL are predictors of precocious clinical coronary heart disease. Clin Chim Acta 413:502\u2013505","journal-title":"Clin Chim Acta"},{"key":"270_CR19","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/0735-1097(95)00384-3","volume":"26","author":"WA Hueb","year":"1995","unstructured":"Hueb WA, Bellotti G, de Oliveira SA, Arie S, de Albuquerque CP,\u00a0Jatene AD et al (1995) The Medicine, Angioplasty or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses. J Am Coll Cardiol 26:1600\u20131605","journal-title":"J Am Coll Cardiol"},{"key":"270_CR20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499\u2013502","journal-title":"Clin Chem"},{"key":"270_CR21","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1373\/clinchem.2004.032383","volume":"50","author":"E Lima","year":"2004","unstructured":"Lima E, Maranh\u00e3o RC (2004) Rapid, simple laser-light scattering method for HDL particle size in whole plasma. Clin Chem 50:1086\u20131091","journal-title":"Clin Chem"},{"key":"270_CR22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1161\/01.RES.4.2.129","volume":"4","author":"JH Bragdon","year":"1956","unstructured":"Bragdon JH, Eder HA, Gould RG, Havel RJ (1956) Lipid nomenclature: recommendations regarding the reporting of serum lipids and lipoproteins made by the Committee on Lipid and Lipoprotein Nomenclature of the American Society for the Study of Arteriosclerosis. Circ Res 4:129","journal-title":"Circ Res"},{"key":"270_CR23","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1038\/oby.2009.446","volume":"18","author":"T Marotta","year":"2010","unstructured":"Marotta T, Russo BF, Ferrara LA (2010) Triglyceride-to-HDL-cholesterol ratio and metabolic syndrome as contributors to cardiovascular risk in overweight patients. Obesity 18:1608\u20131613","journal-title":"Obesity"},{"key":"270_CR24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1475-2840-13-56","volume":"13","author":"MP Hermans","year":"2014","unstructured":"Hermans MP, Ahn SA, Rousseau MF (2014) Novel unbiased equations to calculate triglyceride-rich lipoprotein cholesterol from routine non-fasting lipids. Cardiovasc Diabetol 13:56","journal-title":"Cardiovasc Diabetol"},{"key":"270_CR25","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1464-5491.1988.tb00965.x","volume":"5","author":"PW Seviour","year":"1988","unstructured":"Seviour PW, Teal TK, Richmond W, Elkeles RS (1988) Serum lipids, lipoproteins and macrovascular disease in non-insulin-dependent diabetics: a possible new approach to prevention. Diabet Med 5:166\u2013171","journal-title":"Diabet Med"},{"key":"270_CR26","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/0026-0495(94)90007-8","volume":"43","author":"J Kahri","year":"1994","unstructured":"Kahri J, Syvanne M, Taskinen MR (1994) Plasma cholesteryl ester transfer protein activity in non-insulin-dependent diabetic patients with and without coronary artery disease. Metabolism 43:1498\u20131502","journal-title":"Metabolism"},{"key":"270_CR27","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1373\/clinchem.2003.022558","volume":"49","author":"J Frohlich","year":"2003","unstructured":"Frohlich J, Dobiasova M (2003) Fractional esterification rate of cholesterol and ratio of triglycerides to HDL-cholesterol are powerful predictors of positive findings on coronary angiography. Clin Chem 49:1873\u20131880","journal-title":"Clin Chem"},{"key":"270_CR28","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.bbalip.2011.12.012","volume":"1821","author":"DS Ng","year":"2012","unstructured":"Ng DS (2012) The role of lecithin: cholesterol acyltransferase in the modulation of cardiometabolic risks\u2014a clinical update and emerging insights from animal models. Biochim Biophys Acta 1821:654\u2013659","journal-title":"Biochim Biophys Acta"},{"key":"270_CR29","first-page":"357","volume":"8","author":"J Savel","year":"2012","unstructured":"Savel J, Lafitte M, Pucheu Y, Pradeau V, Tabarin A, Couffinhal T (2012) Very low levels of HDL cholesterol and atherosclerosis, a variable relationship\u2014a review of LCAT deficiency. Vasc Health Risk Manag 8:357\u2013361","journal-title":"Vasc Health Risk Manag"},{"key":"270_CR30","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11883-011-0171-6","volume":"13","author":"X Rousset","year":"2011","unstructured":"Rousset X, Shamburek R, Vaisman B, Amar M, Remaley AT (2011) Lecithin cholesterol acyltransferase: an anti- or pro-atherogenic factor? Curr Atheroscler Rep 13:249\u2013256","journal-title":"Curr Atheroscler Rep"},{"key":"270_CR31","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11745-007-3041-9","volume":"42","author":"RD Couto","year":"2007","unstructured":"Couto RD, Dallan LA, Lisboa LA, Mesquita CH, Vinagre CG,\u00a0Maranhao RC (2007) Deposition of free cholesterol in the blood vessels of patients with coronary artery disease: a possible novel mechanism for atherogenesis. Lipids 42:411\u2013418","journal-title":"Lipids"},{"key":"270_CR32","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1194\/jlr.M200331-JLR200","volume":"44","author":"RD Santos","year":"2003","unstructured":"Santos RD, Hueb W, Oliveira AA, Ramires JA, Maranhao RC (2003) Plasma kinetics of a cholesterol-rich emulsion in subjects with or without coronary artery disease. J Lipid Res 44:464\u2013469","journal-title":"J Lipid Res"},{"key":"270_CR33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","volume":"364","author":"AV Khera","year":"2011","unstructured":"Khera AV, Cuchel M, de la Llera-Moya M, Rodrigues A, Burke MF,\u00a0Jafri K et al (2011) Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. New Eng J Med 364:127\u2013135","journal-title":"New Eng J Med"},{"key":"270_CR34","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.atherosclerosis.2013.03.009","volume":"228","author":"M Triolo","year":"2013","unstructured":"Triolo M, Kwakernaak AJ, Perton FG, de Vries R, Dallinga-Thie GM,\u00a0Dullaart RP et al (2013) Low normal thyroid function enhances plasma cholesteryl ester transfer in type 2 diabetes mellitus. Atherosclerosis 228:466\u2013471","journal-title":"Atherosclerosis"},{"key":"270_CR35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bbalip.2006.11.003","volume":"1771","author":"RP Dullaart","year":"2007","unstructured":"Dullaart RP, de Vries R, Dallinga-Thie GM, van Tol A, Sluiter WJ (2007) Plasma cholesteryl ester transfer protein mass and phospholipid transfer protein activity are associated with leptin in type 2 diabetes mellitus. Biochim Biophys Acta 1771:113\u2013118","journal-title":"Biochim Biophys Acta"},{"key":"270_CR36","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000104810","volume":"16","author":"Y Inukai","year":"2007","unstructured":"Inukai Y, Ito K, Hara K, Yamazaki A, Takebayashi K,\u00a0Aso Y et al (2007) Serum cholesteryl ester transfer protein concentrations are associated with serum levels of total cholesterol, beta-lipoprotein and apoproteins in patients with type 2 diabetes mellitus. Med Princ Pract. 16:367\u2013372","journal-title":"Med Princ Pract."},{"key":"270_CR37","doi-asserted-by":"crossref","first-page":"12235","DOI":"10.1016\/S0021-9258(18)37745-7","volume":"263","author":"RE Morton","year":"1988","unstructured":"Morton RE (1988) Free cholesterol is a potent regulator of lipid transfer protein function. J Biol Chem 263:12235\u201312241","journal-title":"J Biol Chem"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-015-0270-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T09:57:16Z","timestamp":1653040636000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cardiab.com\/content\/14\/1\/107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,14]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["270"],"URL":"https:\/\/doi.org\/10.1186\/s12933-015-0270-8","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,14]]},"article-number":"107"}}